Electron microscopic changes of lymph nodes during correction of sodium glutamate action by melatonin

  • T.V. Harapko Uzhhorod National University, Medical Faculty, Uzhhorod, Ukraine
Keywords: sodium glutamate, melatonin, correction, nucleus, cytoplasm, ribosomes.


The effect of monosodium glutamate on lymphoid organs remains insufficiently studied. Also, no less relevant is the issue of correction of changes caused by the action of monosodium glutamate. The aim of the study was to study the electron microscopic changes in the parenchyma of the lymph nodes of rats under the action of monosodium glutamate for six weeks and during correction with melatonin. The experimental study was performed on 66 white male and female rats of reproductive age. The structure of mesenteric lymph nodes of white rats under the conditions of physiological norm at the electron microscopic level was studied in 10 intact animals. Experimental animals were divided into 4 groups, each with 10 animals. The control was 16 white rats, which instead of a high-calorie diet (HCD) received a standard diet of vivarium. HCD was achieved by adding to the diet of monosodium glutamate at a dose of 0.07 g/kg body weight of rats. The dose of melatonin was 10 mg/kg body weight of rats, administered orally daily at the same time in the afternoon. The electron microscopic structure of the mesenteric lymph nodes of male and female rats of reproductive age of the intact and control groups corresponds to the species norm. The study showed that monosodium glutamate causes changes in the parenchyma of the lymph nodes as in alimentary obesity. After six weeks of HCD, the number of apoptically altered lymphocytes increases. That part of lymphocytes, which has no signs of karyorrhexis or karyolysis, has a karyolemma with deep intussusception, the cytoplasm is enlightened, the tubules of the granular endoplasmic reticulum in cells with signs of edema, dilated, mitochondrial ridges swollen, damaged. There are profound destructive changes in the cellular composition of the organ and violations at the level of all parts of the vascular bed. After six weeks of melatonin correction, the number of macrophages and plasma cells decreased, in some lymphocytes the nucleolus is not clearly expressed, the karyolemma is uneven, the cytoplasm is enlightened, the number of osmophilic (fatty) inclusions decreases both in the intercellular space and in the cytoplasm of the cell. Therefore, the introduction of melatonin led to a significant restoration of the structural organization, and hence the function of this organ.


[1] Alamdari, N. M., Mahdavi, R., Roshanravan, N., Lotfi Yaghin, N., Ostadrahimi, A. R., & Faramarzi, E. (2015). A double-blind, placebo-controlled trial related to the effects of melatonin on oxidative stress and inflammatory parameters of obese women. Horm. Metab. Res., 47, 504-508. doi: 10.1055/s-0034-1384587
[2] Afifi, M. M., & Abbas, A. M. (2011). Monosodium glutamate versus diet induced obesity in pregnant rats and their offspring. Acta Physiol. Hung., 98(2), 177-188. doi: 10.1556/APhysiol.98.2011.2.9
[3] Bhandari, U. (2018). Effect of Embelin in Monosodium Glutamate Induced Obesity in Male Neonatal Wistar Rats. Atheroscler. Suppl., 32, 138. doi: 10.1016/j.atherosclerosissup.2018.04.423
[4] Calvo, J. R., Gonzalez-Yanes, C., & Maldonado, M. D. (2013). The role of melatonin in the cells of the innate immunity: a review. J. Pineal. Res., 55, 103-120. doi: 10.1111/jpi.12075
[5] De Farias,, T. S. M., Cruz, M. M., De Sa, R. C. C., Severi, I., Perugini, J., Senzacqua, M., … Alonso-Vale, M. I. C. (2019). Melatonin Supplementation Decreases Hypertrophic Obesity and Inflammation Induced by High-Fat Diet in Mice. Front. Endocrinol., 10, 750. doi: 10.3389/fendo.2019.00750
[6] Gobato, A. O., Vasques, A. C. J., Zambon, M. P., Barros Filho, A. A., & Hessel, G. (2014). Metabolic syndrome and insulin resistance in obese adolescents. Rev. Paul. Pediatr., 32(1), 55-62. doi: 10.1590/S0103-05822014000100010
[7] Goyal, A., Terry, P. D., Superak, H. M., Nell-Dybdahl, C. L., Chowdhury, R., Phillips, L. S., & Kutner, M. H. (2014). Melatonin supplementation to treat the metabolic syndrome: a randomized controlled trial. Diabetol. Metab. Syndr., 6, 124. doi: 10.1186/1758-5996-6-124
[8] Guo, S.-X., Yan, Y.-Z., Mu, L.-T., Niu, Q., He, J., Liu, J.-M., … Rui, D.-S. (2015). Association of serum free fatty acids with hypertension and insulin resistance among rural uyghur adults in Far Western China. Int. J. Environ. Res. Public Health, 12(6), 6582-6590. doi: 10.3390/ijerph120606582
[9] Hernández-Bautista, R. J., Alarcón-Aguilar, F. J., Escobar-Villanueva, M. D. C., Almanza-Pérez, J. C., Merino-Aguilar, H., Fainstein, M. K., & López-Diazguerrero, N. E. (2014). Biochemical alterations during the obese-aging process in female and male monosodium glutamate (MSG)-treated mice. Int. J. Mol. Sci., 15(7), 11473-11494. doi: 10.3390/ijms150711473
[10] Khaksar, M., Oryan, A., Sayyari, M., Rezabakhsh, A., & Rahbarghazi, R. (2017). Protective effects of melatonin on long-term administration of fluoxetine in rats. Experimental and Тoxicologic Pathology, 69(8), 564-574. doi: 10.1016/j.etp.2017.05.002
[11] Koziróg, M., Poliwczak, A. R., Duchnowicz, P., Koter-Michalak, M., Sikora, J., & Broncel M. (2011). Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. J. Pineal. Res., 50, 261-266. doi: 10.1111/j.1600-079X.2010.00835.x
[12] Krynytska, I., Marushchak, M., Naumova, L., & Mazur, L. (2019). The Toxic Impact of Monosodium Glutamate in Rats. Jordan Medical Journal, 53(2), 91-101.
[13] Martos-Moreno, G. A., Gil-Campos, M., Bueno, G., Bahillo, P., Bernal, S., Feliu, A., … & Vela, A. (2014). Obesity associated metabolic impairment is evident at early ages: spanish collaborative study. Nutr. Hosp., 30(4), 787-793. doi: 10.3305/nh.2014.30.4.7661
[14] Pirozzi, F. F., & Bonini, C. (2015). Metabolic Actions of Melatonin on Obesity and Diabetes: A Light in the Darkness. Cell Biol.: Res. Ther., 4, 2. doi: 10.4172/2324-9293.1000119
[15] Prado, N., Ferder, L., Manucha, W., & Diez, E. (2018). Anti-inflammatory effects of melatonin in obesity and hypertension. Curr. Hypertens. Rep., 20(5), 45. doi: 10.1007/s11906-018-0842-6
[16] Seiva, F. R. F., Chuffa, L. G. A., Braga, C. P., Amorim, J. P. A., & Fernandes, A. A. H. (2012). Quercetin ameliorates glucose and lipid metabolism and improves antioxidant status in postnatally monosodium glutamate-induced metabolic alterations. Food Chem. Toxicol., 50(10), 3556-3561. doi: 10.1016/j.fct.2012.07.009
[17] Szewczyk-Golec, K., Wozniak, A., & Reiter, R. J. (2015). Inter-relationships of the chronobiotic, melatonin, with leptin and adiponectin: implications for obesity. J. Pineal. Res., 59, 277-291. doi: 10.1111/jpi.12257
[18] Trufakin, V. A., Shurlygina, A. V., Dushkin, M. I., Khrapova, M. V., Michurina, S. V., Mel’nikova, E. V., … Tenditnik, M. V. (2014). Effect of melatonin on cellular composition of the spleen and parameters of lipid metabolism in rats with alimentary obesity. Bull. Exp. Biol. Med., 158(1), 42-45. doi: 10.1007/s10517-014-2687-6
[19] Umukoro, S., Oluwole, G. O., Olamijowon, H. E., Omogbiya, A. I., & Eduviere, A. T. (2015). Effect of monosodium glutamate on behavioral phenotypes, biomarkers of oxidative stress in brain tissues and liver enzymes in mice. World J. of Neuroscience, 5, 339-349.
[20] Zanfirescu, A., Cristea, A. N., Nitulescu, G. M., Velescu, B. S., & Gradinaru. D. (2018). Chronic Monosodium Glutamate Administration Induced Hyperalgesia in Mice. Nutrients, 10, 1.
How to Cite
Harapko, T. (2020). Electron microscopic changes of lymph nodes during correction of sodium glutamate action by melatonin. Reports of Morphology, 26(1), 59-64. https://doi.org/10.31393/morphology-journal-2020-26(1)-09